NEW Dividend Portfolio Tracker (DRIPTracker) is Now Live!

Add your stocks and see every dividend they pay you — dates, amounts, and reinvested shares.

GSK plc GSK | NYSE

$50.68 $0.66 | 1.32%

TREND SIGNAL: Signal available — unlock to view

Signal available — unlock to view

|2026-10-21

Next Earnings: Oct 28, 2026

Add to favoritesFavorite

Company Overview:

Market Cap: $100.22B

Trailing PE: 21.5x

FWD PE *: 13.5x

Payout Ratio (TTM): 56.9%

52-Week Range: $42.85 - $61.70

* Forward PE is based on street estimates.

10 Year GSK Performance Metrics:

Total Return (with DRIP): 97.7% (7.05% CAGR)

Total Return (no DRIP): 70.5% (5.48% CAGR)

Share Price: 23.2% (2.11% CAGR)

Yield on Cost (with DRIP): 7.05%

Total Invested: $10,000

Total Value (with DRIP): $19,765

Total Return $ (with DRIP): $9,765

Dividend Increase: -5.5% (-0.58% CAGR)

Dividend Yield (FWD): 3.57% ($1.81)

GSK 10-yr Total Return ($10K invested)

1M 3M 6M YTD 1Y 3Y 5Y 10Y

GSK Share Price

1M 3M 6M YTD 1Y 3Y 5Y 10Y All

GSK Price CAGR:1Y: 14.51%2Y: 15.49%5Y: 4.97%10Y: 2.11%

GSK Dividend Charts

GSK - Dividends

GSK Dividend CAGR:1Y: 6.14%2Y: 8.27%5Y: -2.52%10Y: -0.79%

GSK - Dividend Payout Ratio

GSK Dividend Payout Ratio CAGR:1Y: 417.58%2Y: 0.00%5Y: 15.47%10Y: 3.88%

GSK - Dividend to Free Cash Flow Ratio

GSK Dividend to FCF Ratio CAGR:1Y: -26.26%2Y: -12.53%5Y: -13.67%10Y: -6.85%

Unlock All Reports & Research Dividend Stocks like a BOSS!

Get 3 Months Free with Annual Plan

PRO

$171/yr ($14.25/mo)

7-day free trial

Unlimited Portfolio Tracker
Portfolio - Lots/Sales/Dividends
Portfolio Auto-DRIP
Buy/Sell Signals Dashboard
Stock Fundamentals
Compare Stocks Side-by-Side
Revenue & EPS Estimates
DCF Valuation Modeling

Try it free for 7 days

You save $57/yr (25%)

Most Popular

PREMIUM

$288/yr ($24/mo)

7-day free trial

Everything in Pro
YieldMax PNL Tracker
YieldMax NAV Erosion Alerts
YM ETFs Trend Signals
9/21 EMA Trend Signals
Stocks Dashboard

Try it free for 7 days

You save $96/yr (25%)

ULTRA

$576/yr ($48/mo)

7-day free trial

Everything in Premium
15min & 1hr Intraday Signals
Group & weekly ETF estimates
YouTuber Mode
Trades summary + CSV export
Priority data & support

Try it free for 7 days

You save $192/yr (25%)

GSK Financials: Earnings, Revenue, Cash Flow, Ebitda, Cash/Debt, Shares Float, etc:

GSK - Revenue

GSK Revenue CAGR:1Y: -1.61%2Y: 2.45%5Y: -1.52%10Y: 1.09%

GSK - Earnings Per Share (EPS)

GSK EPS CAGR:1Y: -78.21%2Y: 0.00%5Y: -18.08%10Y: -6.29%

GSK - Net Income

🔓 See the full chart7-day free trial

GSK Net Income CAGR:1Y: -74.21%2Y: 0.00%5Y: -13.89%10Y: -3.72%

GSK - EBITDA

🔓 See the full chart7-day free trial

GSK EBITDA CAGR:1Y: -15.92%2Y: 55.35%5Y: -0.75%10Y: 5.57%

GSK - Free Cash Flow

🔓 See the full chart7-day free trial

GSK Free Cash Flow CAGR:1Y: 51.68%2Y: 24.60%5Y: 9.77%10Y: 4.82%

GSK - Free Cash Flow / Share

🔓 See the full chart7-day free trial

GSK Free Cash Flow / Share CAGR:1Y: 64.48%2Y: 9.92%5Y: -3.01%10Y: -1.75%

GSK - Operating Income

🔓 See the full chart7-day free trial

GSK Operating Income CAGR:1Y: -81.45%2Y: 59.53%5Y: -24.32%10Y: -10.33%

GSK - Gross Profit

🔓 See the full chart7-day free trial

GSK Gross Profit CAGR:1Y: -2.32%2Y: 4.60%5Y: -0.15%10Y: 2.05%

GSK - Shares Outstanding

🔓 See the full chart7-day free trial

GSK Shares Outstanding CAGR:1Y: -0.98%2Y: -0.96%5Y: 0.04%10Y: 0.35%

GSK - Share Buybacks

🔓 See the full chart7-day free trial

GSK Share Buybacks CAGR:1Y: -2.84%2Y: 0.00%5Y: 7.86%10Y: 38.34%

GSK - Stock-Based Comp

🔓 See the full chart7-day free trial

GSK Stock-Based Comp CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%

GSK - Expenses

🔓 See the full chart7-day free trial

GSK Expenses CAGR:1Y: -23.21%2Y: -37.50%5Y: -23.84%10Y: -4.00%

GSK - Revenue vs Net Income

🔓 See the full chart7-day free trial

GSK - EPS vs FCF / Share

🔓 See the full chart7-day free trial

GSK - EPS vs PE Ratio

🔓 See the full chart7-day free trial

GSK - FCF vs FCF / Share

🔓 See the full chart7-day free trial

GSK - FCF vs Stock Based Comp

🔓 See the full chart7-day free trial

GSK - Cash & Debt

🔓 See the full chart7-day free trial

Revenue, EPS, Net Income & Ebitda - Estimates VS Actual:

GSK - REVENUE: Actual + Estimates

🔓 See the full chart7-day free trial

GSK Actual Revenue CAGR:1Y: -1.61%2Y: 2.45%5Y: -1.52%10Y: 1.09%

GSK - EPS: Actual + Estimates

🔓 See the full chart7-day free trial

GSK Actual EPS CAGR:1Y: -78.21%2Y: 0.00%5Y: -18.08%10Y: -6.29%

GSK - NET INCOME: Actual + Estimates

🔓 See the full chart7-day free trial

GSK Actual Net Income CAGR:1Y: -74.21%2Y: 0.00%5Y: -13.89%10Y: -3.72%

GSK - EBITDA: Actual + Estimates

🔓 See the full chart7-day free trial

GSK Actual EBITDA CAGR:1Y: -15.92%2Y: 55.35%5Y: -0.75%10Y: 5.57%

Ratios, Profit Margins & Return on Capital:

GSK - Net Profit Margin

🔓 See the full chart7-day free trial

GSK Net Profit Margin CAGR:1Y: -78.05%2Y: 0.00%5Y: -16.67%10Y: -7.02%

GSK - Gross Profit Margin

🔓 See the full chart7-day free trial

GSK Gross Profit Margin CAGR:1Y: 2.00%2Y: 2.86%5Y: 1.94%10Y: 1.21%

GSK - Price to Earnings

🔓 See the full chart7-day free trial

GSK Price to Earnings CAGR:1Y: 471.90%2Y: 0.00%5Y: 29.94%10Y: 8.45%

GSK - Price To Sales Ratio

🔓 See the full chart7-day free trial

GSK Price To Sales Ratio CAGR:1Y: 27.25%2Y: 10.66%5Y: 8.61%10Y: 0.98%

GSK - Return on Capital Employed

🔓 See the full chart7-day free trial

GSK Return on Capital Employed CAGR:1Y: -7.98%2Y: 114.13%5Y: 11.61%10Y: 5.41%

GSK - Return on Invested Capital

🔓 See the full chart7-day free trial

GSK Return on Invested Capital CAGR:1Y: -4.75%2Y: 109.59%5Y: 7.83%10Y: 0.56%

GSK Dividends Info:

Annual Dividend: $1.808

Forward Yield: 3.57%

Ex-Dividend Date: 2026-08-14

Lifetime Dividends / Share: $62.00

GSK Dividend History: Dates, Payments & Yield list

Below is a schedule of all GSK dividend payments, ex-dates, share price on the day of the payment as well as the annualized yield & forward yield

Ex-Date	Payment Date	Amount	Yield	Forward Yield	Price on Ex-Date
08/14/2026	08/17/2026	$0.452	3.65%	3.6%	$50.28
05/15/2026	05/18/2026	$0.461	3.71%	3.67%	$50.26
02/20/2026	02/23/2026	$0.486	3.27%	3.28%	$59.26
11/14/2025	11/17/2025	$0.417	3.54%	3.51%	$47.53
08/15/2025	08/18/2025	$0.428	4.35%	4.38%	$39.07
05/16/2025	05/19/2025	$0.429	4.56%	4.52%	$37.96
02/21/2025	02/24/2025	$0.401	4.37%	4.32%	$37.08
11/15/2024	11/18/2024	$0.389	4.67%	4.62%	$33.69
08/16/2024	08/19/2024	$0.386	3.74%	3.72%	$41.52
05/16/2024	05/20/2024	$0.376	3.35%	3.37%	$44.59
02/22/2024	02/26/2024	$0.406	3.85%	3.84%	$42.34
11/16/2023	11/20/2023	$0.340	3.95%	3.87%	$35.11
08/17/2023	08/21/2023	$0.361	4.14%	4.18%	$34.55
05/18/2023	05/22/2023	$0.348	3.95%	3.93%	$35.35
02/23/2023	02/27/2023	$0.340	3.86%	3.91%	$34.82
11/17/2022	01/12/2023	$0.317	3.89%	3.61%	$35.15
08/18/2022	10/06/2022	$0.391	4.57%	5.21%	$30.00
05/19/2022	07/01/2022	$0.350	3.21%	3.2%	$43.75
02/24/2022	04/07/2022	$0.622	6.04%	5.38%	$46.23
11/18/2021	01/13/2022	$0.523	5.04%	4.65%	$45.06
08/19/2021	10/07/2021	$0.530	5.07%	5.48%	$38.66
05/20/2021	07/08/2021	$0.527	5.4%	5.27%	$39.97
02/18/2021	04/08/2021	$0.628	7.24%	6.89%	$36.46
11/12/2020	01/14/2021	$0.496	5.25%	5.2%	$38.16
08/13/2020	10/08/2020	$0.491	4.77%	5.29%	$37.16
05/14/2020	07/09/2020	$0.472	4.62%	4.68%	$40.37
02/20/2020	04/09/2020	$0.599	5.61%	6.17%	$38.88
11/14/2019	01/09/2020	$0.489	4.46%	4.19%	$46.65
08/08/2019	10/10/2019	$0.464	4.58%	4.39%	$42.25
05/16/2019	07/11/2019	$0.495	5.04%	4.84%	$40.93
02/21/2019	04/11/2019	$0.597	5.89%	5.83%	$40.94
11/15/2018	01/10/2019	$0.491	4.86%	4.99%	$39.36
08/09/2018	10/11/2018	$0.501	4.9%	5.21%	$38.47
05/10/2018	07/12/2018	$0.530	5.31%	5.08%	$41.75
02/22/2018	04/12/2018	$0.638	6.98%	6.28%	$40.62
11/09/2017	01/11/2018	$0.504	5.63%	5.47%	$36.84
08/09/2017	10/12/2017	$0.496	5.02%	4.84%	$41.02
05/10/2017	07/13/2017	$0.488	4.62%	4.59%	$42.50
02/22/2017	04/13/2017	$0.576	5.62%	5.51%	$41.81
11/02/2016	01/12/2017	$0.464	4.7%	4.76%	$39.01
08/10/2016	10/13/2016	$0.499	4.52%	4.71%	$42.39
05/11/2016	07/14/2016	$0.554	5.25%	5.05%	$43.87
02/17/2016	04/14/2016	$1.252	12.71%	11.74%	$42.64
11/10/2015	01/14/2016	$0.582	5.68%	5.78%	$40.28
08/12/2015	10/01/2015	$0.593	5.38%	6.12%	$38.74
05/13/2015	07/09/2015	$0.577	5.18%	5.52%	$41.80
02/18/2015	04/09/2015	$0.695	5.88%	5.83%	$47.72
11/05/2014	01/08/2015	$0.613	5.43%	5.68%	$43.19
08/06/2014	10/02/2014	$0.648	5.43%	5.68%	$45.63
05/14/2014	07/10/2014	$0.640	4.64%	4.71%	$54.40
02/19/2014	04/10/2014	$0.750	5.38%	5.71%	$52.55
11/13/2013	01/09/2014	$0.616	4.74%	4.66%	$52.84
08/07/2013	10/03/2013	$0.553	4.29%	4.35%	$50.84
05/08/2013	07/11/2013	$0.550	4.33%	4.16%	$52.91
02/20/2013	04/11/2013	$0.689	6.08%	5.68%	$48.52
11/14/2012	01/03/2013	$0.579	5.53%	5.27%	$43.98
08/08/2012	10/04/2012	$0.528	4.48%	4.45%	$47.45
05/09/2012	07/05/2012	$0.549	4.83%	4.77%	$46.01
02/15/2012	04/12/2012	$0.821	7.38%	7.22%	$45.47
11/02/2011	01/05/2012	$0.543	5.02%	4.71%	$46.13
08/03/2011	10/06/2011	$0.521	4.78%	4.92%	$42.37
05/04/2011	07/07/2011	$0.526	4.87%	4.79%	$43.91
02/09/2011	04/07/2011	$0.615	6.43%	6.16%	$39.96
10/27/2010	01/06/2011	$0.507	5.15%	5.19%	$39.05
07/28/2010	10/07/2010	$0.457	5.16%	4.44%	$41.19
05/05/2010	07/08/2010	$0.460	5.08%	5.27%	$34.91
02/10/2010	04/08/2010	$0.574	6.12%	5.91%	$38.86
11/04/2009	01/07/2010	$0.490	4.86%	4.73%	$41.48
07/29/2009	10/08/2009	$0.461	4.8%	4.66%	$39.58
08/13/1997	11/30/-0001	$0.491	2.51%	2.51%	$39.06
03/19/1997	11/30/-0001	$0.727	4.2%	4.2%	$34.63
08/16/1996	11/30/-0001	$0.584	4.15%	4.15%	$28.13
03/22/1996	11/30/-0001	$0.580	4.66%	4.66%	$24.88
09/22/1995	11/30/-0001	$0.774	6.62%	6.62%	$23.38
02/24/1995	11/30/-0001	$0.385	3.83%	3.83%	$20.13
03/04/1998	11/30/-0001	$0.652	2.4%	2.4%	$54.25
08/12/1998	11/30/-0001	$0.496	1.71%	1.71%	$58.00
03/03/1999	11/30/-0001	$0.595	1.93%	1.93%	$61.69
08/11/1999	11/30/-0001	$0.539	2.18%	2.18%	$49.38
03/01/2000	11/30/-0001	$0.785	3.11%	3.11%	$50.44
08/09/2000	11/30/-0001	$0.502	1.78%	1.78%	$56.31
12/27/2000	11/30/-0001	$0.742	2.68%	2.68%	$55.38
05/02/2001	11/30/-0001	$0.287	1.09%	1.09%	$52.58
09/23/1994	11/30/-0001	$0.695	7.77%	7.77%	$17.88
03/14/1994	11/30/-0001	$0.332	3.34%	3.34%	$19.88
05/15/1987	11/30/-0001	$0.042	1.29%	1.29%	$13.06
11/20/1987	11/30/-0001	$0.142	6.22%	6.22%	$9.13
04/18/1988	11/30/-0001	$0.074	3.2%	3.2%	$9.19
11/18/1988	11/30/-0001	$0.061	2.53%	2.53%	$9.63
04/07/1989	11/30/-0001	$0.095	1.68%	1.68%	$11.25
10/05/1989	11/30/-0001	$0.224	3.73%	3.73%	$12.00
03/30/1990	11/30/-0001	$0.151	2.34%	2.34%	$12.88
09/24/1990	11/30/-0001	$0.317	4.68%	4.68%	$13.56
03/15/1991	11/30/-0001	$0.183	1.93%	1.93%	$18.94
09/16/1991	11/30/-0001	$0.384	3.25%	3.25%	$23.63
02/28/1992	11/30/-0001	$0.281	2.01%	2.01%	$28.00
09/21/1992	11/30/-0001	$0.580	4.09%	4.09%	$28.38
03/05/1993	11/30/-0001	$0.305	3.17%	3.17%	$19.25
09/24/1993	11/30/-0001	$0.058	0.6%	0.6%	$19.25
08/01/2001	11/30/-0001	$0.283	0.98%	0.98%	$57.62
10/31/2001	11/30/-0001	$0.284	1.06%	1.06%	$53.40
02/15/2006	11/30/-0001	$0.488	3.82%	3.82%	$51.14
05/10/2006	11/30/-0001	$0.393	2.75%	2.75%	$57.17
08/02/2006	11/30/-0001	$0.406	3.02%	3.02%	$53.80
11/01/2006	11/30/-0001	$0.451	3.41%	3.41%	$52.98
02/14/2007	11/30/-0001	$0.552	3.78%	3.78%	$58.37
05/02/2007	11/30/-0001	$0.481	3.34%	3.34%	$57.68
08/01/2007	11/30/-0001	$0.495	3.84%	3.84%	$51.61
10/31/2007	11/30/-0001	$0.533	4.16%	4.16%	$51.25
02/13/2008	11/30/-0001	$0.627	5.74%	5.74%	$43.66
04/30/2008	11/30/-0001	$0.519	4.71%	4.71%	$44.11
07/30/2008	11/30/-0001	$0.519	4.46%	4.46%	$46.53
10/29/2008	11/30/-0001	$0.475	5.09%	5.09%	$37.32
02/11/2009	11/30/-0001	$0.495	5.58%	5.58%	$35.50
11/02/2005	11/30/-0001	$0.355	2.73%	2.73%	$51.96
08/03/2005	11/30/-0001	$0.348	2.9%	2.9%	$48.00
05/11/2005	11/30/-0001	$0.380	3.04%	3.04%	$50.03
02/20/2002	11/30/-0001	$0.715	2.85%	2.85%	$50.21
05/01/2002	11/30/-0001	$0.555	4.6%	4.6%	$48.26
07/31/2002	11/30/-0001	$0.311	3.15%	3.15%	$39.50
10/30/2002	11/30/-0001	$0.308	3.27%	3.27%	$37.68
02/19/2003	11/30/-0001	$0.465	5.09%	5.09%	$36.56
05/07/2003	11/30/-0001	$0.317	3.03%	3.03%	$41.90
07/30/2003	11/30/-0001	$0.286	2.92%	2.92%	$39.22
10/29/2003	11/30/-0001	$0.300	2.77%	2.77%	$43.25
02/18/2004	11/30/-0001	$0.520	4.9%	4.9%	$42.49
05/12/2004	11/30/-0001	$0.353	3.36%	3.36%	$42.05
08/04/2004	11/30/-0001	$0.366	3.57%	3.57%	$40.98
11/03/2004	11/30/-0001	$0.365	3.31%	3.31%	$44.15
02/16/2005	11/30/-0001	$0.444	3.74%	3.74%	$47.43
04/29/2009	11/30/-0001	$0.409	5.3%	5.3%	$30.85

Projected Future Returns & Dividends for GSK

Based on past 10-year performance, here are GSK growth metrics:

Share price CAGR of +2.11%
Dividend CAGR of -0.58%

Using GSK CAGR metrics, we can estimate that your initial $10000 investment, over the next 10 years, should grow as follows:

	GSK (DRIP)	GSK - No DRIP
Current Price	$50.68	$50.68
Start Shares	197.32	197.32
Start Value	$10,000	$10,000

After 10 years:
Final Share Count	270.65	197.32
Dividends Payment	$0.43	$0.43
Annual Dividends	$462	$337
Yield on cost	4.62%	3.37%
Share Price	$62.45	$62.45
Total Dividends	$4,094	$3,476
Final Value	$16,902	$15,798

Estimated Future Value + Dividends - GSK

NOTE: Above numbers are our estimate based on GSK's Dividend and Price CAGR over past 10 years. These numbers should only be considered as "potential future returns"! DRIP assumes reinvesting dividends; No-DRIP assumes collecting dividends as cash.

We cannot guarantee that your actual returns will meet these estimates.

Get the best Dividend Stock Research Tools:

Get 3 Months Free with Annual Plan

PRO

$171/yr ($14.25/mo)

7-day free trial

Unlimited Portfolio Tracker
Portfolio - Lots/Sales/Dividends
Portfolio Auto-DRIP
Buy/Sell Signals Dashboard
Stock Fundamentals
Compare Stocks Side-by-Side
Revenue & EPS Estimates
DCF Valuation Modeling

Try it free for 7 days

You save $57/yr (25%)

Most Popular

PREMIUM

$288/yr ($24/mo)

7-day free trial

Everything in Pro
YieldMax PNL Tracker
YieldMax NAV Erosion Alerts
YM ETFs Trend Signals
9/21 EMA Trend Signals
Stocks Dashboard

Try it free for 7 days

You save $96/yr (25%)

ULTRA

$576/yr ($48/mo)

7-day free trial

Everything in Premium
15min & 1hr Intraday Signals
Group & weekly ETF estimates
YouTuber Mode
Trades summary + CSV export
Priority data & support

Try it free for 7 days

You save $192/yr (25%)

Company Info

GSK plc (GSK) had its IPO on 1980-03-28, and is traded on NYSE stock exchange.

GSK plc, a global pharmaceutical entity founded in 1715 and headquartered in Brentford, United Kingdom, dedicates its efforts to the research, development, and manufacturing of a wide array of medical solutions. Until May 2022, the company was known as GlaxoSmithKline plc. Its primary objective is to prevent and treat illnesses by producing both vaccines and a comprehensive range of specialty and general medicines for markets across the United Kingdom, the United States, and internationally. The company's operations are organized into two key divisions: Commercial Operations and Total R&D. Its extensive vaccine portfolio includes immunizations against shingles, meningitis, respiratory syncytial virus (RSV), seasonal and pandemic influenza, and polio. Beyond preventative care, GSK provides diverse therapeutic products covering critical areas such as HIV, oncology, respiratory and immunology conditions, and other specialized medical fields. This also encompasses inhaled treatments for chronic respiratory ailments like asthma and chronic obstructive pulmonary disease (COPD), along with antibiotics for various infections. Innovation at GSK is frequently driven by strategic partnerships. Notable collaborations include an agreement with CureVac to advance mRNA-based influenza vaccines, and alliances with Wave Life Sciences and Elsie Biotechnologies focused on developing oligonucleotide platforms. Furthermore, GSK has established two distinct strategic collaborations with Relation to progress therapeutics for fibrotic diseases and osteoarthritis. The company is also engaged in a multi-target strategic alliance aimed at developing pioneering treatments for individuals suffering from Parkinson's disease, and a partnership with Flagship Pioneering to identify novel medicines and vaccines.

GSK website: https://www.gsk.com

Get Full Access to All Reports with DRIPCalc PRO

Get 3 Months Free with Annual Plan

PRO

$171/yr ($14.25/mo)

7-day free trial

Unlimited Portfolio Tracker
Portfolio - Lots/Sales/Dividends
Portfolio Auto-DRIP
Buy/Sell Signals Dashboard
Stock Fundamentals
Compare Stocks Side-by-Side
Revenue & EPS Estimates
DCF Valuation Modeling

Try it free for 7 days

You save $57/yr (25%)

Most Popular

PREMIUM

$288/yr ($24/mo)

7-day free trial

Everything in Pro
YieldMax PNL Tracker
YieldMax NAV Erosion Alerts
YM ETFs Trend Signals
9/21 EMA Trend Signals
Stocks Dashboard

Try it free for 7 days

You save $96/yr (25%)

ULTRA

$576/yr ($48/mo)

7-day free trial

Everything in Premium
15min & 1hr Intraday Signals
Group & weekly ETF estimates
YouTuber Mode
Trades summary + CSV export
Priority data & support

Try it free for 7 days

You save $192/yr (25%)

Loading signals…

DCF Model — GSK

Value from:

EPS (TTM)icompany profit per share over the last 12 months

EPS Growth %ihow fast profit per share grows each of the next 5 years — prefilled with what analysts expect

EPS growth after year 5 (forever)ithe slower pace once the fast 5 years are over — only drives years 6-10 of the price path below

Exit multiple (PE in 5 yrs)iwhat buyers pay per $1 of profit in 2031 — prefilled with today’s forward PE

Desired return %/yrithe yearly return you want from buying today — the S&P has done ~14%/yr, ask for more from a single stock

FCF growth %/yr (next 5 yrs)ihow fast free cash flow grows while the company is still expanding fast

Years of fast FCF growthihow many years the fast growth lasts before the business settles down

FCF growth after year 5 (forever)ithe slow, steady pace once the company is mature — usually 2-3%, near inflation. Must stay below your target return

Risk-free rate %iwhat a 10-yr US treasury pays with zero risk — the floor any risky stock must beat

Your target return %/yrithe yearly return you want for taking this risk — rule of thumb: risk-free rate + extra for risk

FCF base ($M, TTM)ilast 12 months of free cash flow, added up from reported quarters

Include dividends in returnidividends hand you part of the return in cash, so the share price needs to climb less

Pay up to today

—

vs current price $50.68

—

Cash flow & implied price by year

FCF is negative or missing for this company (common for banks) — the model discounts EPS instead.

EPS is negative or missing for this company — Simple mode uses free cash flow per share instead.

Free cash flow today

—

grows for the next years

Then mature

—

every future dollar counted back to today

Pile of today-dollars

—

÷ shares

Implied price path

Year	FCF	Implied price

Sensitivity — fair value: growth ↓ × target return →

× Free Portfolio Tracker

Own GSK? See every dividend it's paid you

Add your GSK shares to a free account and every payment you've received is listed — dated, in dollars — with reinvested shares counted and monthly totals. Room for 4 more stocks.

✓Every GSK dividend you've received, dated, with the amount
✓Reinvested (DRIP) shares counted for you
✓Monthly totals across up to 5 stocks

Add GSK free →

Free plan · up to 5 holdings